Elang Mahkota Teknologi Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Elang Mahkota Teknologi Tbk. trades at Rp515 (market cap 31.94T, 23.61M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Elang Mahkota Teknologi Tbk. is far larger — about 190.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Elang Mahkota Teknologi Tbk. is more actively traded (23.61M versus 71K). Which is the better fit depends on your goals.
| EMTK | OBAT | |
|---|---|---|
Market Cap | 31.94T | 167.37B |
Volume | 23.61M | 71K |
Lot | 236.13K | 710 |
Turnover | 12.22B | 17.51M |
Average Price | 517.66 | 246.63 |
Value | 12.22B | 17.51M |
Indicative Equilibrium Price | 515 | 246 |
Indicative Equilibrium Volume | 8.64K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Elang Mahkota Teknologi Tbk (the Company) was established based on Notarial Deed No.7 dated August 3, 1983 of Soetomo Ramelan, S.H.. The Company is engaged in services, specifically in providing technology, media, and telecommunication services, trading, construction, and industry. Company started its commercial operation in 1984.
Read more on EMTK →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →